Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION, USP
| Report ID | 78454 |
| Drug Identification Number | 02387468 |
| Brand name | LABETALOL HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | LABETALOL HYDROCHLORIDE INJECTION, USP |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LABETALOL HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 20ML 1VL |
| ATC code | C07AG |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-05-05 |
| Estimated end date | |
| Actual end date | 2023-01-10 |
| Shortage status | Resolved |
| Updated date | 2024-12-10 |
| Company comments | ID 10718 was resolved in error on Mar-8-2019. Reopened report in this ID. Original 'Actual Start Date' of 2018-05-05 was used. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-04-30 | English | Compare |
| v3 | 2019-04-10 | English | Compare |
| v2 | 2019-03-13 | French | Compare |
| v1 | 2019-03-13 | English | Compare |